{
    "title": "BioMarin's dwarfism therapy gets FDA nod for expanded use",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12655223/U-S-FDA-approves-expanded-use-BioMarins-therapy-type-dwarfism.html",
    "date": "2023-10-20",
    "keywords": [
        "voxzogo",
        "therapy",
        "use",
        "drug",
        "pratik",
        "jain",
        "age",
        "form",
        "dwarfism",
        "disorder",
        "gene",
        "company",
        "growth",
        "europe",
        "health",
        "regulator",
        "friday",
        "biomarin",
        "food",
        "administration",
        "fda",
        "achondroplasia",
        "fdas",
        "approval",
        "pathway",
        "stature",
        "mutation",
        "roctavian",
        "bleeding",
        "companys",
        "decision",
        "trial",
        "safety",
        "efficacy",
        "profile",
        "guggenheim",
        "analyst",
        "label",
        "year",
        "forecast",
        "bridgebio",
        "infigratinib",
        "transcon",
        "cnp",
        "development",
        "australia",
        "brazil",
        "japan",
        "review",
        "reporting",
        "khushi",
        "mandowara",
        "bengaluru",
        "editing",
        "kuber"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}